Checkpoint Therapeutics News

Checkpoint Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Aug 19 17:18 ET

Checkpoint Therapeutics | 8-K: Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates

Aug 12 08:50 ET

Checkpoint Therapeutics | 8-K: Current report

Jul 25 16:09 ET

Checkpoint Therapeutics | 8-K: Current report

Jul 3 08:45 ET

Checkpoint Therapeutics | 8-K: Current report

Jun 24 07:50 ET

Checkpoint Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 24 16:51 ET

Checkpoint Therapeutics | 8-K: Current report

May 14 07:34 ET

Checkpoint Therapeutics | 8-K: Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates

May 10 08:49 ET

Checkpoint Therapeutics | DEFA14A: Others

Apr 2 06:10 ET

Checkpoint Therapeutics | DEF 14A: Definitive information statements

Apr 2 06:09 ET

Checkpoint Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 29 17:08 ET

Checkpoint Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 22 17:23 ET

Checkpoint Therapeutics | 8-K: Current report

Mar 22 08:57 ET

Checkpoint Therapeutics | 8-K: Current report

Mar 18 16:14 ET

Checkpoint Therapeutics | 8-K: Current report

Feb 2 17:17 ET

Checkpoint Therapeutics | 8-K: Current report

Jan 30 17:04 ET

Checkpoint Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Checkpoint Therapeutics | 8-K: Current report

Dec 18, 2023 07:10 ET

Checkpoint Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 17, 2023 17:02 ET

Checkpoint Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 17, 2023 17:01 ET